IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

a16z Capital Management, L.L.C.

Q2 2025 Holdings

Filed 2025-08-14 | 10 holdings | $312.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$101.1M2,748,52332.3%
Omada Health Inc(OMDA)COM68170A108$84.4M4,614,57427.0%
Block Inc(XYZ)CL A852234103$69.1M1,016,69722.1%
Maze Therapeutics Inc(MAZE)COM578784100$20.9M1,702,2256.7%
Bioage Labs Inc(BIOA)COM09077V100$13.4M3,233,1704.3%
Nautilus Biotechnology Inc(NAUT)COM63909J108$12.8M17,653,9174.1%
Erasca Inc(ERAS)COM29479A108$3.6M2,862,5001.2%
Opendoor Technologies Inc(OPEN)COM683712103$3.3M6,200,8211.1%
Camp4 Therapeutics Corp(CAMP)COM13463J101$3.1M2,125,3391.0%
Ginkgo Bioworks Holdings Inc(DNA)CL A NEW37611X209$1.2M108,5680.4%